Interesting pick, army. o/s is a bit scary, but if they consistently and aggressively continue with the share buy back this could be a diamond in the rough. Looks like R&D expense is done for awhile, now that they have their patent, and have registered their product with the FDA. That should free up more funds for the share buyback program. Will definitely be keeping this one on the radar--thanks!
btw--you might want to check out AOB, too. ;)
Maybe ALXA, too. I jumped on this one Friday when it plunged. Am expecting a bounce here, just don't know how soon. Hopefully soon though, lol!
glty!
News 
Market Data 
Discover 
AI
